Skip to main content
Top

27-03-2024 | Chronic Inflammatory Bowel Disease | Research letter

Phosphomannomutase 2-congenital disorder of glycosylation presenting with very early onset inflammatory bowel disease

Authors: Meltem Comert, Tugba Guler, Anna Carina Ergani, Meltem Gumus, Ebru Marzioglu Ozdemir, Hasibe Artac

Published in: Indian Journal of Gastroenterology

Login to get access

Excerpt

A 13-month-old girl was referred to pediatric gastroenterology due to intractable diarrhea, vomiting, feeding difficulties and failure to thrive. She had 10-12 episodes of mucousy diarrhea per day with no blood. After the introduction of complementary foods into her diet, she began to vomit four to five times a day. She had been hospitalized 10 times due to unexplained fever since the age of two months. Her parents were first-degree cousins. On physical examination, she had facial dysmorphism with a flat nasal bridge, a prominent forehead, anteverted nares, almond-shaped eyes, a thin upper lip and retro-micrognathia. Her weight and height were below − 2 standard deviation score (SDS). She also had oral moniliasis, inverted nipples, hepatomegaly, hypotonicity, microcephaly and perianal ulceration. The laboratory tests revealed the following: WBC count, 13.5 × 103/μL; Hb, 8.5 g/dL; albumin, 2.42 g/dL; and total protein, 4.3 g/dL. Her C-reactive protein level was high (52.1 mg/L) and the stool culture and the stool sample for parasites, amebiasis and Clostridium difficile were all negative. The fecal calprotectin level was very high (> 300,000 μg/g). Immunological evaluation revealed hypogammaglobulinemia (IgG 394 mg/dL, IgA 50 mg/dL, IgM 33.5 mg/dL) and reduced CD4+T cell ratio (21.1%, 2185/mm3). The expression levels of lipopolysaccharide-responsive beige-like anchor protein (LRBA), cytotoxic T lymphocyte antigen 4 (CTLA4), dedicator of cytokinesis 8 (DOCK8) and forkhead box p3 (FOXP3) were normal. …
Literature
6.
go back to reference Kiparissi F, Dastamani A, Palm L, et al. Phosphomannomutase 2 (PMM2) variants leading to hyperinsulinism-polycystic kidney disease are associated with early-onset inflammatory bowel disease and gastric antral foveolar hyperplasia. Hum Genet. 2023;142:697–704.CrossRefPubMedPubMedCentral Kiparissi F, Dastamani A, Palm L, et al. Phosphomannomutase 2 (PMM2) variants leading to hyperinsulinism-polycystic kidney disease are associated with early-onset inflammatory bowel disease and gastric antral foveolar hyperplasia. Hum Genet. 2023;142:697–704.CrossRefPubMedPubMedCentral
Metadata
Title
Phosphomannomutase 2-congenital disorder of glycosylation presenting with very early onset inflammatory bowel disease
Authors
Meltem Comert
Tugba Guler
Anna Carina Ergani
Meltem Gumus
Ebru Marzioglu Ozdemir
Hasibe Artac
Publication date
27-03-2024
Publisher
Springer India
Published in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01555-9
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.